% Expired Patents = 14.3

EPO Patents = 1

Trademarks = 5

Forward Citations = 12

Loading Chart...

7 inventors (with patents filed for the assignee):

Matthew Merrill Carter (6 out of 15 patents)

Paul Daniel Donohoue (6 out of 47 patents)

Daniela Roth (1 out of 2 patents)

4. Ranjan Batra (1 out of 2 patents)

5. Daniel A Knowland (1 out of 1 patent)

6. Rachel A Adams (1 out of 1 patent)

7. Rea Lardelli Markmiller (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12037588 - Compositions and methods comprising engineered short nuclear RNA (snRNA) (2024-07-16),

2. 11939606 - CRISPR-associated (Cas) protein (2024-03-26),

3. 11932883 - CRISPR-associated (Cas) protein (2024-03-19),

4. 11293011 - CRISPR-associated (CAS) protein (2022-04-05),

5. 11028381 - CRISPR-associated (Cas) protein (2021-06-08),

6. 10889808 - CRISPR-associated (CAS) protein (2021-01-12),

7. 10876101 - CRISPR-associated (Cas) protein (2020-12-29),

Company Overview

Locanabio is a biotechnology company focused on developing precision genetic medicines for neurological disorders. The company utilizes their proprietary delivery platform to create targeted therapies that aim to treat a broad range of neurodegenerative diseases. Locanabio is dedicated to advancing the field of gene therapy to improve the lives of patients with unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#704 in San Diego, CA

#9,508 in California

#39,929 in US

San Diego, CA, United States of America

Locanabio, Inc.

Forward Citations = 12

7 inventors:

Matthew Merrill Carter (6 out of 15 patents)

Paul Daniel Donohoue (6 out of 47 patents)

Daniela Roth (1 out of 2 patents)

4. Ranjan Batra (1 out of 2 patents)

5. Daniel A Knowland (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Locanabio, Inc.. Retrieved from https://idiyas.com/company/locanabio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]